Industry giants Clive Meanwell, M.D., and John Maraganore, Ph.D., have unveiled Corsera Health, a new biotech aiming to ...

Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results ...

What if generative AI could design life-saving antibiotics, not just art and text? In a new Cell Biomaterials paper, Penn ...

Dr. Andrew Evens, who completed a Rutgers Executive MBA in 2022, describes how the program helped him to transition from a practicing physician and research to positions of management and leadership ...

Co-founded by RNA interference pioneer John Maraganore and former Medicines Company head Clive Meanwell, Corsera Health is developing diagnostic tools and medicines for heart health.